Detalhe da pesquisa
1.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med;
383(19): 1827-1837, 2020 11 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32459919
2.
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med;
382(24): 2327-2336, 2020 06 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32275812
3.
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
Clin Infect Dis;
73(11): e3996-e4004, 2021 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33031500
4.
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
Clin Infect Dis;
73(11): e4166-e4174, 2021 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32706859
5.
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
JAMA;
324(11): 1048-1057, 2020 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32821939
6.
Sofosbuvir/velpatasvir for 12â¯weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.
J Hepatol;
71(4): 660-665, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31195062
7.
Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.
Liver Int;
38(9): 1552-1561, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29297980
8.
Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.
JAMA Netw Open;
5(12): e2244505, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36454570
9.
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
Open Forum Infect Dis;
8(7): ofab278, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34282406
10.
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.
Lancet Gastroenterol Hepatol;
5(10): 918-926, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32531259
11.
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes.
Elife;
82019 09 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31478832
12.
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.
AIDS;
25(9): 1179-87, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21593619